IRIS
BRUNO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.585
AS - Asia 8.928
EU - Europa 6.884
SA - Sud America 1.487
Continente sconosciuto - Info sul continente non disponibili 496
AF - Africa 327
OC - Oceania 23
AN - Antartide 1
Totale 30.731
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.236
CN - Cina 3.593
SG - Singapore 2.187
IE - Irlanda 1.305
BR - Brasile 1.134
IT - Italia 1.055
HK - Hong Kong 1.023
VN - Vietnam 1.006
RU - Federazione Russa 916
DE - Germania 790
FI - Finlandia 612
UA - Ucraina 594
FR - Francia 489
GB - Regno Unito 342
SE - Svezia 292
BD - Bangladesh 232
IN - India 228
CA - Canada 170
ZA - Sudafrica 167
AR - Argentina 121
MX - Messico 95
NL - Olanda 91
IQ - Iraq 84
JP - Giappone 78
TR - Turchia 78
ES - Italia 67
PL - Polonia 67
ID - Indonesia 60
PK - Pakistan 54
EC - Ecuador 53
BE - Belgio 49
VE - Venezuela 47
CO - Colombia 42
CZ - Repubblica Ceca 36
SA - Arabia Saudita 35
UZ - Uzbekistan 33
MA - Marocco 31
PH - Filippine 29
TN - Tunisia 29
AT - Austria 28
CL - Cile 24
LT - Lituania 24
MY - Malesia 23
JM - Giamaica 21
IL - Israele 19
PY - Paraguay 19
AU - Australia 17
CH - Svizzera 17
AZ - Azerbaigian 16
EG - Egitto 16
JO - Giordania 16
KZ - Kazakistan 15
PE - Perù 15
AE - Emirati Arabi Uniti 14
RO - Romania 14
CR - Costa Rica 13
IR - Iran 13
UY - Uruguay 13
KE - Kenya 12
NP - Nepal 12
ET - Etiopia 11
PT - Portogallo 11
AL - Albania 10
BO - Bolivia 10
BY - Bielorussia 10
DZ - Algeria 10
EU - Europa 10
LB - Libano 10
KG - Kirghizistan 9
SN - Senegal 9
TH - Thailandia 9
MU - Mauritius 8
NG - Nigeria 8
NI - Nicaragua 8
OM - Oman 8
PA - Panama 8
GE - Georgia 7
HU - Ungheria 7
BG - Bulgaria 6
HN - Honduras 6
HR - Croazia 6
KR - Corea 6
LV - Lettonia 6
MD - Moldavia 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
RS - Serbia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GY - Guiana 4
LK - Sri Lanka 4
LY - Libia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SR - Suriname 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
CG - Congo 3
CM - Camerun 3
Totale 30.174
Salva come PNG Salva come JPEG
Città #
San Jose 1.590
Dublin 1.301
Chandler 1.254
Ashburn 1.112
Singapore 1.104
Hong Kong 991
Dallas 923
Jacksonville 725
Beijing 661
Nanjing 604
Council Bluffs 582
Boardman 475
Ho Chi Minh City 341
Los Angeles 341
Lauterbourg 313
New York 286
Princeton 268
Hanoi 241
Nanchang 237
Milan 236
Lawrence 235
Munich 230
Wilmington 219
Helsinki 216
Shenyang 193
Moscow 183
Hebei 177
Changsha 172
Medford 166
Redondo Beach 144
Johannesburg 139
Ann Arbor 137
Shanghai 134
Jiaxing 130
Buffalo 129
São Paulo 128
Turku 120
Pavia 116
Santa Clara 116
Tianjin 97
Hangzhou 96
Seattle 85
Orem 79
Frankfurt am Main 71
Tokyo 71
Da Nang 62
Columbus 60
San Francisco 60
Denver 59
Chennai 57
Brooklyn 56
Falkenstein 56
Montreal 56
Warsaw 55
Woodbridge 55
Houston 54
Toronto 51
Nuremberg 50
Chicago 49
Rome 47
Brussels 46
Norwalk 46
The Dalles 46
Verona 44
Haiphong 41
London 40
Rio de Janeiro 39
Mexico City 38
Atlanta 37
Phoenix 36
Stockholm 36
Poplar 35
Pune 34
Guangzhou 33
Washington 33
Amsterdam 31
Fairfield 31
Baghdad 30
Biên Hòa 28
Tashkent 28
Draper 27
Boston 26
Ankara 25
Belo Horizonte 25
Manchester 25
Zhengzhou 24
Curitiba 21
Düsseldorf 21
Quito 21
Turin 21
Brasília 20
Dhaka 20
Hải Dương 20
Mumbai 20
Ningbo 19
Paris 19
Des Moines 18
Jinan 18
Piscataway 18
Secaucus 18
Totale 19.153
Salva come PNG Salva come JPEG
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 351
Hepatitis B virus genotype distribution in HIV-1 coinfected patients 258
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 178
AGGRESSIVE INTERFERON THERAPY IN HIV-HCV COINFECTED PATIENTS 172
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 163
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 161
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 157
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 156
Aggressive daily interferon therapy in HIV-HCV coinfected patients 154
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 153
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 152
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 150
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 142
Hospitalizations Associated With Mental Health Conditions Among Adolescents in the US and France During the COVID-19 Pandemic 140
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 140
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 138
The Pavia consensus statement 136
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 136
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 134
Daptomycin Pharmacokinetics and Pharmacodynamics in Patients on Methadone Substitution Therapy 133
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 131
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 129
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 129
Mice and rabbits: Animal models for HIV-1 infection 127
Host factors affecting the outcome of treatment of hepatitis C 126
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 126
Consensus conference on TIPS management: Techniques, indications, contraindications 125
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 124
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 123
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore) 123
[New trends in the therapy of cryptococcosis in AIDS patients] 123
Fungal Osteomyelitis: A Systematic Review of Reported Cases 122
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 122
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 122
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 120
COVID vaccination and asthma exacerbation: might there be a link? 120
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 119
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 119
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 119
Emerging biological agents for hepatitis C 118
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 117
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 117
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 117
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 116
AISF position paper on liver disease and pregnancy 116
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. 115
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 115
Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy 115
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 115
The early phase of the COVID-19 epidemic in Lombardy, Italy 114
Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy? 114
A case of leprosy in a nonendemic country 114
A clinical case of sepsis due to staphylococcus pettenkoferi 113
Challenges for hepatitis C patients coinfected with HIV. 112
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 112
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 111
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 111
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts. 110
Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease 110
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study 109
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 109
Lung ultrasound presentation of COVID-19 patients: phenotypes and correlations 108
Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice 108
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 108
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol 108
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 107
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 107
Management of hepatitis C in human immunodeficiency virus-infected patients 106
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 106
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 105
Transfusion-transmitted virus infection in HIV-1-seropositive patients 105
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study 104
Cutaneous septic emboli from Candida glabrata in a haematological patient 104
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 103
General issues on microbial translocation in HIV-infected patients 103
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study 103
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 102
HCV-VIRAL KINETICS IN DIFFERENT CATEGORIES OF PATIENTS: DAILY VERSUS BID INDUCTION INTERFERON THERAPY 102
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 102
Hepatotoxicity and nelfinavir: a meta-analysis 102
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 102
Ultrasound in the diagnosis of gallbladder ascariasis 102
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 102
Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C 102
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project 102
Spatial and temporal dynamics of hepatitis B virus d genotype in europe and the mediterranean basin. 101
Prioritization of high-cost new drugs for HCV: making sustainability ethical 101
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 100
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects 100
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a 99
The role of the rs12979860 polymorphism of the interleukin-28b as a predictor of sustained virological response after antiviral therapy in patients with hemophilia and chronic hepatitis C 99
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 99
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis. 99
Treatment of echinococcal abdominal cysts 99
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 98
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 98
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 98
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 98
Management of hepatitis C positive patients undergoing active treatment for malignancies: a position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT) 98
High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk 98
Totale 12.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.078 0 14 22 11 28 30 23 73 76 18 151 632
2022/20233.645 386 248 40 286 323 368 7 192 1.541 49 145 60
2023/20241.725 173 271 73 88 222 378 91 130 13 64 74 148
2024/20255.349 111 349 103 179 82 238 472 362 1.279 279 599 1.296
2025/202612.930 934 953 1.343 1.468 1.479 548 2.368 557 1.088 990 734 468
2026/2027800 246 554 0 0 0 0 0 0 0 0 0 0
Totale 30.731